(Q48687986)

English

Quality of life, depression and fatigue in mildly disabled patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon beta-1a: 3-year results from the COGIMUS (COGnitive Impairment in MUltiple Sclerosis) study

scientific article published on 18 April 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/21502310

Quality of life, depression and fatigue in mildly disabled patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon beta-1a: 3-year results from the COGIMUS (COGnitive Impairment in MUltiple Sclerosis) study (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/21502310

relapsing-remitting multiple sclerosis

0 references

multiple sclerosis

0 references

quality of life

1 reference

based on heuristic

inferred from title

cognitive dysfunction

1 reference

based on heuristic

inferred from title

Stefano Bastianello

4

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/21502310

Orietta Picconi

6

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/21502310

object named as

D Centonze

9

0 references

object named as

M Trojano

3

0 references

Giuseppe Salemi

0 references

author name string

F Patti

1

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/21502310

M P Amato

2

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/21502310

M R Tola

5

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/21502310

S Cilia

7

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/21502310

S Cottone

8

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/21502310

C Gasperini

10

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/21502310

COGIMUS Study Group

11

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/21502310

publication date

18 April 2011

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/21502310

Multiple Sclerosis Journal

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/21502310

17

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/21502310

8

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/21502310

991-1001

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/21502310

The neuropsychiatry of multiple sclerosis: a review of recent developments

1 reference

https://api.crossref.org/works/10.1177%2F1352458511401943

21 January 2018

Deterioration in the health-related quality of life of persons with multiple sclerosis: the possible warning signs

1 reference

https://api.crossref.org/works/10.1177%2F1352458511401943

21 January 2018

Redefining functionality and treatment efficacy in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1177%2F1352458511401943

21 January 2018

Doctors and patients don't agree: cross sectional study of patients' and doctors' perceptions and assessments of disability in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458511401943

21 January 2018

The association of illness severity, self-reported cognitive impairment, and perceived illness management with depression and anxiety in a multiple sclerosis clinic population.

1 reference

https://api.crossref.org/works/10.1177%2F1352458511401943

21 January 2018

Longitudinal correlates of fatigue in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1177%2F1352458511401943

21 January 2018

Quality of life in patients with multiple sclerosis: the impact of fatigue and depression.

1 reference

https://api.crossref.org/works/10.1177%2F1352458511401943

21 January 2018

Influence of Interferon beta treatment on quality of life in multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.1177%2F1352458511401943

21 January 2018

Multiple sclerosis beyond EDSS: depression and fatigue

1 reference

https://api.crossref.org/works/10.1177%2F1352458511401943

21 January 2018

Depression in multiple sclerosis: review and theoretical proposal

1 reference

https://api.crossref.org/works/10.1177%2F1352458511401943

21 January 2018

Fatigue in multiple sclerosis is related to disability, depression and quality of life.

1 reference

https://api.crossref.org/works/10.1177%2F1352458511401943

21 January 2018

Multiple sclerosis-related cognitive changes: a review of cross-sectional and longitudinal studies.

1 reference

https://api.crossref.org/works/10.1177%2F1352458511401943

21 January 2018

Fatigue and processing speed are related in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458511401943

21 January 2018

The association between cognitive impairment and quality of life in patients with early multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1177%2F1352458511401943

21 January 2018

The Rao's Brief Repeatable Battery and Stroop Test: normative values with age, education and gender corrections in an Italian population

1 reference

https://api.crossref.org/works/10.1177%2F1352458511401943

21 January 2018

Development of a Rating Scale for Primary Depressive Illness

1 reference

https://api.crossref.org/works/10.1177%2F1352458511401943

21 January 2018

Measuring the functional impact of fatigue: initial validation of the fatigue impact scale.

1 reference

https://api.crossref.org/works/10.1177%2F1352458511401943

21 January 2018

Health-related quality of life in multiple sclerosis: effects of natalizumab

1 reference

https://api.crossref.org/works/10.1177%2F1352458511401943

21 January 2018

Improvement of health-related quality of life in relapsing remitting multiple sclerosis patients after 2 years of treatment with intramuscular interferon-beta-1a.

1 reference

https://api.crossref.org/works/10.1177%2F1352458511401943

21 January 2018

A longitudinal study of quality of life and side effects in patients with multiple sclerosis treated with interferon beta-1a

1 reference

https://api.crossref.org/works/10.1177%2F1352458511401943

21 January 2018

Factors influencing quality of life in multiple sclerosis patients: disability, depressive mood, fatigue and sleep quality

1 reference

https://api.crossref.org/works/10.1177%2F1352458511401943

21 January 2018

Quality of life in 1000 patients with early relapsing-remitting multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458511401943

21 January 2018

Intellectual enrichment lessens the effect of brain atrophy on learning and memory in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458511401943

21 January 2018

Effects of education level and employment status on HRQoL in early relapsing-remitting multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1177%2F1352458511401943

21 January 2018

Predicting quality of life in multiple sclerosis: accounting for physical disability, fatigue, cognition, mood disorder, personality, and behavior change.

1 reference

https://api.crossref.org/works/10.1177%2F1352458511401943

21 January 2018

Identifiers

10.1177/1352458511401943

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/21502310

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/21502310

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48687986&oldid=2206822397"